Showing results (261-270 of 287) with videos related to

Sort By:
Pageof 29
Bioorganic & Medicinal Chemistry Letters|February 18, 2011
1-((3S,4S)-4-amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetesKim M Andrews, David A Beebe, John W Benbow, et al.
Plos One|April 4, 2020
A restriction enzyme reduced representation sequencing approach for low-cost, high-throughput metagenome profilingMelanie K Hess, Suzanne J Rowe, Tracey C Van Stijn, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1Robert L Dow, Jian-Cheng Li, Michael P Pence, et al.
Applied and Environmental Microbiology|February 1, 2024
Diversity and community structure of anaerobic gut fungi in the rumen of wild and domesticated herbivoresCasey H Meili, Moustafa A TagElDein, Adrienne L Jones, et al.
Space Science Reviews|February 6, 2026
Geodetic Investigations of the Europa Clipper MissionG Steinbrügge, R S Park, J H Roberts, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2009
(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitorMark J Ammirati, Kim M Andrews, David D Boyer, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Cochlear implants with dexamethasone-eluting electrode arrays reduce foreign body response in a murine model of cochlear implantation and human subjectsMuhammad Taifur Rahman, Brian Mostaert, Peter Eckard, et al.
RSC Medicinal Chemistry|June 7, 2021
Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 2R Kirk, A Ratcliffe, G Noonan, et al.
Scientific Reports|August 20, 2025
Dexamethasone-eluting cochlear implants reduce inflammation and foreign body response in human and murine cochleaeMuhammad Taifur Rahman, Brian J Mostaert, Peter Eckard, et al.
RSC Medicinal Chemistry|June 7, 2021
Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 1R Kirk, A Ratcliffe, G Noonan, et al.
Pageof 29